Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation.

Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation. - Johoku-Cilnidipine trial of renal function and blood pressure for clinical evaluation.(J-CIRCLE)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003956

Enrollment

150

Registered

2010-08-05

Start date

2009-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Interventions

Administration of Cilnidipine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Administration of amlodipine more than three months,and urinary albumin qualitative is positivity(1+ and above) of hypertensive patients.

Exclusion criteria

Exclusion criteria: Following patients will be excluded from this study. 1.Pregnant women or suspected of being pregnant. 2.Severe liver dysfunction.

Design outcomes

Primary

Measure	Time frame
1.Office blood pressure 2.Home blood pressure 3.Urinary albumin excretion	—

Secondary

Measure	Time frame
1.Heart rate 2.Serum uric acid 3.Adverse events	—

Countries

Japan

Contacts

Public ContactUchida shunya

Teikyo University School of Medicine Internal medicine

s_uchida@netjoy.ne.jp03-4964-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026